Epidural Abscess Treatment Market Report 2026

Epidural Abscess Treatment Market Overview

• Epidural Abscess Treatment market size has reached to $43.78 billion in 2025 • Expected to grow to $62.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Rising Prevalence Of Neurological Disorders Drives Growth In The Epidural Abscess Treatment Market • North America was the largest region in 2025.

What Is Covered Under Epidural Abscess Treatment Market?

Epidural abscess treatment refers to the treatment of a rare disorder that is characterized by an infection in the area between the bones of the skull or spine and the membranes covering the brain and spinal cord. Epidural abscess treatment is used to manage symptoms, slow down the progression of the disease and prevent complications. The main types of epidural abscesses are intracranial and intraspinal. An intracranial epidural abscess refers to an infection between the skull's bones and the membranes encasing the brain and spinal cord. These can be treated by various treatments, including antifungals, antibiotics and surgery, which are used by various end-users, such as hospitals, pharmacies, specialty clinics and others.

What Is The Epidural Abscess Treatment Market Growth Forecast?

The epidural abscess treatment market size is expected to see strong growth in the next few years. It will grow to $62.27 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advanced imaging access, early intervention protocols, antimicrobial innovation, hospital infrastructure expansion, clinician awareness. Major trends in the forecast period include increased use of early diagnostic imaging, rising reliance on broad-spectrum antibiotics, growth in surgical intervention rates, expansion of hospital-based infection care, focus on preventing neurological complications.

Global Epidural Abscess Treatment Market Segmentation

1) By Type: Intracranial, Intraspinal 2) By Treatment: Antifungal, Antibiotics, Surgery 3) By End-User: Hospital, Pharmacy, Specialty Clinics, Other End-Users Subsegments: 1) By Intracranial: Brain Abscess, Subdural Abscess, Epidural Abscess in the Cranium 2) By Intraspinal: Cervical Epidural Abscess, Thoracic Epidural Abscess, Lumbar Epidural Abscess, Sacral Epidural Abscess

What Are The Drivers Of The Epidural Abscess Treatment Market?

The increasing prevalence of neurological disorders is expected to propel the growth of the epidural abscess treatment market going forward. A neurological disorder is a medical condition affecting the nervous system, including the brain, spinal cord, and nerves. Common neurological disorders include acute spinal cord injury, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and more. Epidural abscess treatment is used for neurological disorders. It involves prompt surgical drainage of the abscess and antibiotic treatment to prevent spinal cord and nerve compression and relieve pressure on the spinal cord and nerves. For instance, in April 2025, according to the Alzheimer's Association, a US-based nonprofit organization, in 2025, 7.2 million people aged 65 and older are living with Alzheimer’s disease. Further, total annual costs of caring for people living with Alzheimer’s and other dementias (excluding unpaid care) are projected to be $384 billion in 2025. Therefore, the increasing prevalence of neurological disorders is driving the growth of the epidural abscess treatment industry. Rising intravenous drug use is expected to propel the epidural abscess treatment market going forward. Intravenous drug use refers to the practice of injecting drugs directly into the bloodstream using a hypodermic needle and syringe. Intravenous drug use can lead to epidural abscess when contaminated injection equipment or drugs introduce bacteria or pathogens into the bloodstream, increasing the incidence of this condition and creating demand for specialized care, treatments, and prevention programs. For instance, in June 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, methamphetamine (53%) was the most commonly reported last drug injected nationally. Further, the proportion of participants who said methamphetamine was the drug they injected most often was 59% in 2024 and 56% in 2023. Therefore, rising intravenous drug use will drive the growth of the epidural abscess treatment industry. The rise in healthcare expenditures is expected to propel the growth of the epidural abscess treatment market going forward. Health expenditures refer to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help focusing on health. A rise in healthcare expenditure plays a significant role in epidural abscess treatment, as it would result in the development of more effective therapies and medical technologies used for epidural abscess treatment. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that in 2023, healthcare expenditure in the UK was approximately $362.08 billion (£292 billion), reflecting a nominal increase of 5.6%. Further, healthcare spending as a share of gross domestic product (GDP) decreased slightly to 10.9% in 2023 from 11.1% in 2022. Therefore, the rise in healthcare expenditures is driving the growth of the epidural abscess treatment industry.

Key Players In The Global Epidural Abscess Treatment Market

Major companies operating in the epidural abscess treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Limited, Kyowa Hakko Kirin Co. Ltd., Hikma Pharmaceuticals plc, Intas Pharmaceuticals Limited, Alembic Limited, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals

Regional Outlook

North America was the largest region in the epidural abscess treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Epidural Abscess Treatment Market?

The epidural abscess treatment market consists of revenues earned by entities by providing surgical intervention, myelography, magnetic resonance imaging (MRI) and computed tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. The epidural abscess treatment market also includes sales of vancomycin, gentamicin and ceftriaxone. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Epidural Abscess Treatment Market Report 2026?

The epidural abscess treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the epidural abscess treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.